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Congenital corneal opacification (CCO) encompasses a broad spectrum of disorders that have different etiologies,
including genetic and environmental. Terminology used in clinical phenotyping is commonly not specific enough to
describe separate entities, for example both the terms Peters anomaly and sclerocornea have been ascribed to a clinical
picture of total CCO, without investigating the presence or absence of iridocorneal adhesions. This is not only confusing
but also unhelpful in determining valid genotype-phenotype correlations, and thereby revealing clues for pathogenesis.
We undertook a systematic review of the literature focusing on CCO as part of anterior segment developmental anomalies
(ASDA), and analyzed its association specifically with chromosomal abnormalities. Genes previously identified as being
associated with CCO are also summarized. All reports were critically appraised to classify phenotypes according to
described features, rather than the given diagnosis. Some interesting associations were found, and are discussed.
Congenital  corneal  opacities  (CCO)  occur  with  a
prevalence of 6/100,000 newborns in Europe [1]. The causes
are  complex,  and  include  genetic  and  pre-  and  peri-natal
environmental factors. To date controversy exists on the exact
genetic causes of CCO with some of this controversy muddied
by  inaccurate  clinical  phenotyping  [2].  This  issue  of
phenotyping  is  crucial  if  we  are  to  progress  in  our
understanding of the heterogeneous genetic causes of this
severe  condition,  which  frequently  causes  blindness  from
birth,  and  its  association  with  other  anterior  segment
developmental anomalies (ASDA) of the eye.
In simplistic terms, the embryology of the ocular anterior
segment structures can be summarized as the formation of the
bi-layered optic cup from the forebrain neuroectoderm, the
invagination  and  separation  of  the  lens  vesicle  from  the
overlying surface ectoderm, and the anterior migration of
surrounding mesenchymal progenitor cells mainly of neural
crest origin to participate in the formation of the anterior
segment  tissues,  the  cornea,  the  iris,  and  the  iridocorneal
angle. When the tissue destined to become the cornea fails to
separate from the underlying tissues, or fails to form properly
with the appropriate differentiated cell content and under the
influence  of  specific  growth  factors  generated  by  the
surrounding  tissues,  then  the  resulting  cornea  lacks  the
structure and function to maintain transparency and appears
as a CCO [3]. Elucidating the genetic factors that normally
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orchestrate this process is crucial for the understanding why
CCO can occur due to DNA mutation and/or environmental
factors.
According to the Online Mendelian Inheritance In Man
Database (OMIM) the term sclerocornea is commonly used
to describe a congenital malformation of the cornea, such that
the boundary between the cornea and the sclera is obscured
(OMIM 269400). Usually the involvement is limited to the
peripheral part of the cornea but it may extend to the entire
cornea,  so-called  sclerocornea  totalis.  Peters  anomaly
according to OMIM consists of a central corneal leukoma (an
opaque white spot), absence of the posterior corneal stroma
and Descemet membrane, and a variable degree of iris and
lenticular attachments to the central aspect of the posterior
cornea [4] (OMIM 604229). Various degrees of iridocorneal
and/or  keratolenticular  adhesion  including  Peters  anomaly
and peripheral scleralization of the cornea were first described
as  “anterior  chamber  cleavage  syndrome”  by  Reese  and
Ellsworth  in  1966  [5].  More  recently  terms  like  anterior
segment dysgenesis (ASD), or ASDA have been used instead
to refer to a broad spectrum of disorders affecting the anterior
segment, including Axenfeld Rieger syndrome, congenital
glaucoma,  congenital  cataract,  anterior  segment
mesenchymal dysgenesis, and corneal plana and aniridia, all
of which may exhibit corneal pathology [6].
Genes thus far implicated in CCO include paired box 6
(PAX6),  pituitary  homeobox  2  (PITX2),  forkhead  box  C1
(FOXC1),  forkhead  box  E3  (FOXE3),  beta  1,3-
galactosyltransferase-like  (B3GALTL),  and  keratocan
(KERA), indicating the genetic heterogeneity of the condition
(Table 1). Dominant mutations of PAX6, PITX2, FOXC1,
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1625FOXE3, and recessive mutations of B3GALTL and KERA
have been identified as the cause of ASDA including CCO in
some patients. Although none have been identified that cause
a  significant  proportion  of  cases  of  CCO.  Chromosomal
abnormalities have also been implicated in CCO, including
some  that  do  not  incorporate  these  genes.  Identifying  a
chromosomal anomaly that is associated with a particular
phenotype provides a rapid way of localizing at least one area
on the genome that may harbor a gene(s) contributing to that
condition. This has proved to be a very useful method in
revealing the genetic causes of numerous monogenic diseases.
We undertook a comprehensive review of the literature
to evaluate the type of CCO and the associated genetic causes,
particularly the range of chromosomal anomalies reported
thus far. We classified the phenotypic entities by the described
features and not necessarily by the terminology used by the
authors, as classification and nomenclature varies and this is
confusing  when  trying  to  establish  phenotype-genotype
correlations.
All primary developmental CCOs were included in our
search, i.e., those apparently resulting from a default that
occurs during the complex developmental process of anterior
segment formation. In the literature the term sclerocornea is
often confusingly used to describe total corneal opacification,
where the status of anterior segment structures is not known.
Wherever possible we assigned the CCOs to the subcategories
of Peters anomaly (PA), sclerocornea with cornea plana (S-
CNA), and total “sclerocornea” (total opacification of the
cornea: S-CCO) based on the clinical features described in
each paper. The designation PA was only used when there was
evidence or description of iridocorneal or keratolenticular
adhesion resulting in central or eccentric, localized or total
corneal opacification (Figure 1). S-CNA was only designated
as such if the phenotype was typical of Cornea Plana 2, CNA2
(OMIM 217300 [35]; Figure 2). This entity is characterized
by peripheral corneal scleralization but a view of the eye
through the center of the cornea is possible, and there is always
accompanying  cornea  plana.  CNA2  can  be  caused  by
recessive  mutation  in  KERA  encoding  the  keratan  sulfate
proteoglycan, keratocan (OMIM 603228), which is important
for corneal transparency. S-CCO was designated in cases in
which all of the cornea is opaque and resembles the sclera
(Figure 3).
Although  not  classically  grouped  under  ASDA,  our
search did not specifically exclude those corneal dystrophies
that  are  present  from  birth,  that  is  congenital  hereditary
endothelial  dystrophy  (CHED),  posterior  polymorphous
corneal  dystrophy  (PPCD),  congenital  stromal  corneal
dystrophy  (CSCD)  and  X-linked  endothelial  corneal
dystrophy (XLECD), as they are primary, congenital, and
concern the formation of the cornea [36]. We excluded storage
disorders such as mucopolysaccharidosis type IV, which can
present from birth in the form of CCO, along with all other
metabolic  causes  and  storage  disorders,  as  etiologically
distinct.  Corneal  opacification  of  non-genetic  causation,
metabolic/storage disorders, and corneal dystrophies with the
exception of CHED, PPCD, CSCD and XLECD, were also
excluded.
We performed searches on PubMed, using the following
strategy:
#1; congenital corneal opacity OR Peters anomaly
OR  corneal  opacity  OR  corneal  opacification  OR
leukoma 4468
#2;  (“chromosome  disorders”[MeSH  Terms]  OR
(“chromosome”[All  Fields]  AND  “disorders”[All
Fields])  OR  “chromosome  disorders”[All  Fields]  OR
(“chromosome”[All  Fields]  AND  “abnormalities”[All
Fields])  OR  “chromosome  abnormalities”[All  Fields]
OR  “chromosome  aberrations”[MeSH  Terms]  OR
(“chromosome”[All  Fields]  AND  “aberrations”[All
Fields]) OR “chromosome aberrations”[All Fields] OR
(“chromosome”[All  Fields]  AND  “abnormalities”[All
Fields] 35276
#3;  anomaly  OR  abnormality  OR  deletion  OR
translocation OR ring OR trisomy OR monosomy 501777
#4; #2 OR #3 AND #1 409
We  excluded  the  articles  regarding  animal  studies  or
exclusively  laboratory  work.  All  remaining  articles  were
reviewed, as well as all relevant references, which were not
cited in Pubmed. We applied no language or time period
restriction.  Search  results  were  cross-referenced  with  the
OMIM,  DECIPHER,  and  London  Dysmorphology
Databases, by using the term “corneal opacity.” Retrieved
articles and their relevant bibliographies were reviewed. Any
cases of microphthalmia with severe disruption of the globe
and no specific mention of CCO, or cases of CCO attributed
to isolated congenital glaucoma, were noted but not included
in the detailed analysis of CCO and chromosomal disorders.
Reports of mutations were reviewed, but again not included
in the analysis hereafter. Finally, for the purposes of this study,
it was not possible to include any papers reporting a genotype
associated with CCO but without describing the phenotype,
or papers discussing a CCO phenotype without a reported
genetic abnormality.
DISCUSSION
In total 254 published studies were collected, of which 101
had no case of human CCO with an associated chromosomal
abnormality to include in our analysis, and were therefore
excluded. No case of congenital corneal dystrophy came up
in the search. The majority of analyzed papers were case
reports, small series of patients or familial incidence of CCO,
but also a few review articles that summarized reported cases
and added new ones, or that were essentially used for cross-
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1626checking and retrieving all relevant references. The findings
were  grouped  according  to  the  associated  chromosome
anomaly for ease of reference. Known monogenic causes of
CCO are listed in Table 1, where the references cited are those
specifically describing a CCO in association with each gene
and other associated phenotypes are also listed.
No studies were found to associate CCO with genetic
disruption in chromosomes 7, 15, 16, 19, and 20. BenEzra et
al. [37] reported microphthalmia with CCO in a patient and
PA in his sibling, both of whom presented unusual sister
chromatid disjunction. Wertelecki et al. [38] described a case
of  bilateral  PA  associated  with  abnormal  centromere-
chromatid  apposition  (ACCA).  Although  interesting,  this
association is not informative for a candidate locus/gene.
Chromosome X: Xp22.3 syndrome is reported in a series
of studies with a similar range of phenotypes. Temple et al.
[39]  and  Al-Gazali  et  al.  [40]  first  described  a  clinical
syndrome in 1990 comprising linear skin defects at birth,
congenital  microphthalmia  with  CCO  (MLS  –
Microphthalmia  with  Linear  Skin  defects  or  MIDAS  –
Microphthalmia,  Dermal  Aplasia  and  Sclerocornea),
associated with Xp22.2 chromosome breakpoint or deletion.
Ocular phenotypic expression is variable, including severe
microphthalmia in the form of orbital cyst, posterior stromal
corneal  opacity  with  peripheral  synechiae  [40],  S-CCO
[39-41],  microcornea  [42,43],  PA  [44],  and  intrafamilial
variable  expression  [45].  Several  papers  reporting  Xp22
microdeletion  with  MLS  [43,45-50]  suggest  that  severe
Figure 1. Iridocorneal and keratolenticular adhesions. Peters anomaly (PA) classically describes a congenital corneal opacity resulting from
an iridocorneal (A, B) or keratolenticular adhesion (C, D). The opacity may be central (C, D) and may take up a small part or the whole of
the cornea, or may be eccentric (A, B). It is unreliable to ascribe this term judging only from the clinical picture without making use of
ultrasonography, notably ultrasound biomicroscopy (UBM; B, D), which helps visualize the structures of the anterior segment and prove or
disprove the presence of adhesions (B, D). The use of UBM in A and B shows contact between the cornea and iris (iridocorneal adhesion)
and in C and D contact between the cornea and the anterior lenticular surface (keratolenticular adhesions), resulting in disorganization and
loss of clarity in the central cornea, confirming the diagnosis of PA. NB. These opacities are avascular (see Figure 3) and in these cases the
lens is of a normal size.
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1627microphthalmia is often associated with severe disruption of
the anterior segment and secondary CCO.
Ropers  et  al.  [51]  described  a  case  with  a  balanced
Xp22/3q12 translocation presenting with Aicardi syndrome
and right microphthalmic eye with corneal opacity, whereas
Donnenfeld  et  al.  [46],  in  1990,  reported  a  case  with  an
unbalanced  Xp22/3p22  translocation  showing  features
suggestive  of  Aicardi  or  Goltz  syndrome,  together  with
unilateral microphthalmia and S-CCO. Naritomi et al. [43]
presented two cases with Xp22.3 deletion, microphthalmia
with corneal opacity, and combined partial phenotypes of both
Aicardi and Goltz syndromes. Aicardi syndrome is a triad of
callosal agenesis, infantile spasms, and chorioretinal lacunae;
Goltz syndrome is focal dermal hypoplasia. Both conditions
are described as having X-linked dominant inheritance with
in utero lethality in males. In some reported cases only the
feature of corpus callosum agenesis is associated with Xp22
deletion and MLS [41,52,49]. It is plausible to assume that
these conditions may be associated with a contiguous gene
deletion [43], or that clinical overlap can be seen as a result
of genetic heterogeneity and variable penetrance [53], or due
to any of the following factors: mosaicism, skewed patterns
of  X-inactivation,  and  variable  viability  of  mutated  cells
[42].
Glaucoma in cases of MLS or MIDAS associated with
disruption of Xp22.1–3 region has been described [54-56]. All
three reports describe sclerocornea in some of the affected
cases but Cape et al. describes a variable phenotype ranging
from anophthalmia and S-CNA, to total corneal opacity with
PA, whereas Mucke et al. clearly show an ectatic right cornea
and left S-CCO. In addition, Paulger et al. [57] describe a case
of MLS with bilateral microphthalmia and CCO, congenital
glaucoma, and lens absence in one eye and thin lens in the
other. This suggests that the primary problem is not corneal:
in other words, corneal opacification is secondary to a primary
intraocular  event.  This  intraocular  event  may  affect  the
iridotrabecular region (hence the glaucoma cases) or the iris
alone (explaining the iridocorneal adhesions and/or the partial
aniridia) [55]. It seems reasonable therefore to suggest that
this region on the X chromosome may contain genes that
affect the growth/development of the iris, its root and/or the
trabecular meshwork.
Bleyl et al. [52] report a mother and son with a pericentric
inversion of the X chromosome, disturbing the Xp22.3 as well
as the Xq27 regions, and presenting with PA and sclerocornea
without  microphthalmia.  In  the  mother,  PA  is  confirmed
histopathologically by the absence of Descemet’s membrane
in  the  cornea,  and  the  presence  of  iridocorneal  adhesions
[58]. However the son is diagnosed with complete bilateral S-
CCO, as no evidence of iridocorneal adhesions is found on
ultrasonography. This latter is not ultrasound biomicroscopy
as  stated,  however  the  authors  do  attempt  to  classify
phenotypes  according  to  specific  features.  In  fact,  the
ultrasound  shows  no  evidence  of  a  normal  lens.  The
phenotype shown by Bleyl et al. [52] (Figure 2B in their
article) is that described by our group previously to be caused
by a failure of the lens to form properly. It is suggested by the
authors  that  X-linked  sex-determining  region  Y  box  3
(SOX3), localized close to the Xq27 breakpoint, may possibly
be associated with the ocular anomalies. SOX3 is a gene that
promotes neuronal differentiation and is implicated in the
development of the midline forebrain structures. No other
Figure 2. Sclerocornea. This is a case of
sclerocornea,  i.e.,  peripheral
scleralization  of  the  cornea,
accompanied by the feature of cornea
plana (CNA2, OMIM 217300) which in
this  review  we  designate  S-CNA  to
distinguish  it  from  total  corneal
opacification  (S-CCO,  see  Figure
3A,B). In S-CNA the anterior segment
is otherwise normal.
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including  whole  gene  deletions  and  intragenic  mutations
within the gene [59,60].
Sakurai et al. [61] report a case of mosaic trisomy X
associated with unilateral S-CNA in an infant with Dandy-
Walker syndrome, together with ipsilateral microphthalmia,
persistent pupillary membrane, iris hypoplasia, and bilateral
optic disc coloboma. On the other hand, Lloyd et al. [62]
present four patients with mosaic Turner syndrome, where
ocular  findings  included  trabecular  meshwork  dysgenesis
with congenital glaucoma, and Rieger anomaly. The authors
hypothesize that mosaicism causing defective neural crest cell
migration may be at the origin of the ocular developmental
anomalies.
Chromosome 1: Steffensen et al. [63] reported a boy
presenting with partial trisomy 1q31-qter and small eyes with
corneal opacities in association with systemic malformations.
No further clinical details are given. There are subsequent
reports  of  partial  trisomy  1q32-qter  associated  with
goniodysgenesis and cataract [64] or glaucoma [65], without
mention of corneal problems.
David et al. [66] presented a case of bilateral PA and
secondary glaucoma with a balanced translocation between
chromosomes  1  and  7.  The  authors  suggested  that  the
disrupted genes in the reciprocal areas, transforming growth
factor-beta 2 (TGFbeta2) in 1q41 and/or histone deacetylase
9 (HDAC9) in 7p21, may be contributors to the pathogenesis
of PA perhaps through decreased gene dosage. This has not
been further investigated in the literature so far.
We found no cases of CCO associated with aberrations
in 1p32, which is the locus harboring FOXE3. This gene is a
forkhead transcription factor that has been implicated in early
lens and anterior segment formation, mutations of which have
been found in dominantly inherited ASDA and cataract, as
well  as  in  recessive  primary  congenital  aphakia  with
secondary anterior segment dysgenesis [6,7,67]. This locus
may not show enough instability for translocations/deletions
Figure 3. Total corneal opacification. Two typical examples of the phenotype designated as total congenital corneal opacification. S-CCO
(A-D). This condition confusingly, has been previously described clinically as sclerocornea in the literature. However, anterior segment
imaging using UBM shows that the lens has failed to form normally in case A and B and that in case C and D there is failure of the lens (L)
to separate from the cornea (ILA) and there is an abnormal zonular ciliary complex (Z); this suggests another primary lens problem leading
to a secondary CCO. Note both opacities are vascularized.
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fetus.
Finally,  a  single  report  presents  the  association  of
Goldenhar syndrome, including unilateral corneal dermoid,
with an unbalanced translocation resulting in 1p36.33 trisomy
and  16p13.3  monosomy  [68].  The  significance  of  this  is
unclear.
Chromosome 2: MacDonald et al. [69] reported a case of
partial trisomy 2q32-qter and monosomy of 6p (resulting from
a  2:6  translocation)  with  S-CCO,  progressive  corneal
staphyloma  and  aniridia.  The  significance  of  this  case  is
unclear.
Gambrelle et al. [70] described a case with interstitial
deletion of 2q24-q32 and microcephaly, limb malformation,
and ocular anomalies. Although microphthalmia is stated to
be present, the axial length given is not abnormal for 34 weeks
gestation.  Microcornea  is  therefore  a  possible  alternative
diagnosis in this case. The corneal opacities mentioned are not
described. Similarly, Franceschini et al. present a case with
interstitial deletion 2q31q33 as having microphthalmia, but
the  patient's  photograph  shows  normal  palpebral  fissure
aperture,  suggesting  that  the  globes  were  not  small  [71].
Again, this could possibly be mislabelled microcornea. The
same  deletion  caused  left  corneal  opacity,  mild
microphthalmia, and narrow palpebral fissures in the case
described by Young et al. the same year [72], and bilateral
blepharophimosis,  asymmetric  microphthalmia  in  another
case presented by Benson et al. [73], but no clinical details are
given.
Finally, several other reports, including Boles et al. [74],
describe 2q24-q31 deletion presenting with bilateral retinal
coloboma,  right  iris  coloboma,  mild  ptosis,  and  short
palpebral  fissures,  but  without  microphthalmia,  and  the
cornea is not commented on. It can be thus concluded that
2q31 harbours a gene important for ocular morphogenesis, but
contribution to corneal morphogenesis in particular is not
possible to infer from the available data.
Unilateral microphthalmia with PA, as well as multiple
systemic malformations, was found in a girl with interstitial
deletion 2q14-q21 [75]. Severe developmental anomalies and
bilateral microphthalmia with cataract were described in a
case with del2q21q24 [76]. Finally, two siblings with bilateral
PA, persistent fetal vasculature, and systemic abnormalities
were described by Kivlin et al. [77] in 1986, although 2q21
disruption, due to a balanced translocation, was only present
in one of the two, and the authors question the association. All
these anomalies appear to concern the development of the eye
as a whole, rather than the cornea primarily.
Heathcote et al. [78] reported a case of dup2p21-p25 with
multiple dysmorphic features presenting with both primary
and secondary corneal anomalies: microcornea and thickened
Bowman's membrane with glycosaminoglycan deposition, as
well as persistent vascular pupillary membrane with corneal
focal Descemet's membrane and stroma disruption in areas of
attachment.
Interestingly, sine oculis homeobox homolog 3 (SIX3), a
transcription factor gene expressed in the anterior forebrain
and eyes during early vertebrate development, is located in
2p21. It is found mutated in holoprocencephaly, but it also
appears that Six3 plays a role in regulating the development
of the vertebrate eye anterior segment [79,80].
Furthermore, a locus associated with primary congenital
glaucoma lies in 2p21 [81]. Finally, the CYP1B1 gene, which
has been implicated in congenital glaucoma as well as PA, is
located in 2p22 (Table 1).
Chromosome 3: In papers published regarding ASDA
and chromosome 3 anomalies, the common area of interest
appears  to  be  3q21–28.  Translocations,  duplications  and
trisomies affecting this area lead to variable but severe eye
abnormalities ranging from an intracranial rudimentary eye
and anophthalmos to microphthalmia with CCO [82-85]. This
again suggests that the CCO described here is secondary to
globe disruption. The inference is that this region may contain
genes  that  are  involved  upstream  in  organization  of  the
developing eye.
One such gene is SOX2, located in 3q26.3-q27, mutations
in  which  have  been  shown  to  cause  anophthalmia  and
microphthalmia in association with other variable forebrain
abnormalities  [11,12,86].  SOX2  codes  for  a  transcription
factor that controls the expression of several genes involved
in  embryonic  development,  thus  being  critical  for  early
embryogenesis and for embryonic stem cell pluripotency.
Chromosome 4: A large number of papers present the
association  of  4q25  deletion/disruption  with  features  of
Axenfeld-Rieger syndrome, the associated corneal pathology
usually being prominent Schwalbe's line [87-94]. Some of the
cases  present  associated  microphthalmia  [87],  and/or
microcornea [88,92,95-97].
Studies quantifying gene dosage in such patients suggest
that the phenotype is the result of PITX2 haploinsufficiency
[94,98,99]  or  changes  in  its  regulatory  elements  [100].
PITX2 (pituitary homeobox 2), formerly RIEG1, is a gene on
chromosome 4q25 coding for a paired-bicoid homeodomain
transcription factor expressed during eye development [101,
102]. PITX2 physically interacts with FOXC1, and these two
proteins appear to participate in a common pathway, which
can explain how altered gene dosage of FOXC1 can produce
a phenotype similar to that found in mutations/deletions of
PITX2 [103].
It is interesting that there have been two reports of PA
with  a  PITX2  mutation  [13,104]  but  no  chromosomal
abnormality  involving  4q25  has  ever  reported  PA/
sclerocornea. The patient described by Arikawa et al. [104]
presented unilateral PA, proven by UBM, as part of a whole
eye  disruption,  including  a  persistent  hyaloid  artery.  It  is
unclear if the patient described by Doward et al. [2] truly
Molecular Vision 2011; 17:1624-1640 <http://www.molvis.org/molvis/v17/a181> © 2011 Molecular Vision
1630presented PA, as no ultrasonography was performed and no
fundal  view  was  possible  through  the  total  corneal
opacification  with  peripheral  vascularisation.  The
contralateral eye of the patient showed typical ARA. PA might
then be regarded as the very severe end of spectrum of ARA,
whereby  iridocorneal  adhesions  are  so  disruptive  for  the
cornea that it completely opacifies. Vascularisation of the
cornea usually indicates some sort of intraocular insult in
cases of ASDA.
On the other hand, there has been a case of unilateral PA
in association with multiple midline defects and a familial
chromosome 4 inversion, affecting 4q12 and 4q13.3, and not
4q25  [105].  This  is  a  unilateral  “whole  eye”  disruption:
microphthalmia  with  anterior  dysgenesis,  cataract  and
dysplastic retina.
Finally, two cases combined Rieger's anomaly [106] or
PA and microphthalmia [107] with 4p- deletion syndrome
(Wolf-Hirschhorn syndrome). Genetic analysis was only done
by DNA autoradiography at the time, so there is insufficient
information regarding chromosome breakpoints to locate a
possible disease-associated gene.
Chromosome 5: There has only been a single report of
iridocorneal adhesions resulting in very mild corneal opacity
in a case of partial trisomy 5q [108]. The authors mention
defects in Descemet's membrane but they do not explain how
this was ascertained, since there is no histopathology report.
The significance of this genotype-phenotype correlation is
unclear.
Chromosome 6: FOXC1 has been shown to play a role in
the  regulation  of  embryonic  and  ocular  development.
Mutations in this gene cause various glaucoma phenotypes
including primary congenital glaucoma, autosomal dominant
iridogoniodysgenesis  anomaly,  and  Axenfeld-Rieger
anomaly.
There is abundant evidence that deletions affecting the
6p24–25 region bearing FOXC1 result not only in Axenfeld-
Rieger syndrome but also in corneal opacities, the majority of
which  by  far  are  due  to  iridocorneal  rather  than
keratolenticular adhesions [109-118]. More severe disruption
of the iridotrabecular area may lead to further corneal insults
resulting in corneal vascularisation [113]. Again the corneal
opacity appears to be a secondary phenomenon. Conversely,
a few reports describe 6p deletions in patients without ocular
dysgenesis [119,120], suggesting that disruption of FOXC1
leads to incomplete penetrance of ocular abnormalities.
There is description of bilateral S-CNA in an infant with
an  interstitial  deletion  of  6p22.3-p24,  presenting  with
systemic  and  dysmorphic  features  but  no  other  ocular
pathology  [121].  It  may  be  that  this  primary  corneal
dysgenesis was due to disruption of FOXC1, its regulatory
elements, a different gene, or of a combination of these. For
example, transcription factor AP-2 alpha (TFAP2A) lies in
6p24  and  has  been  found  to  be  mutated  in  patients  with
branchio-oculo-facial  syndrome  who  present  with
colobomatous microphthalmia and corneal clouding among
other features, suggesting that TFAP2A plays a role in ocular
embryogenesis [14,15]. This interesting association remains
to be confirmed.
Tabbara et al. [122] described a case of ARA combined
with bilateral microcornea, incomplete aniridia, and cataract,
in association with a presumptive isochromosome 6. This is
an extreme phenotype of ocular dysgenesis, where corneal
involvement is part of a “whole eye” disruption.
In  the  only  paper  reporting  duplication  of  6p25,  the
cornea shows increased central corneal thickness and reduced
corneal diameter, while maintaining normal endothelial cell
morphology and density [123].
Chromosome  8:  Trisomy  8  mosaicism  has  been
associated with CCO, often unilateral. Photographs of these,
where available [124-129], overwhelmingly display a clinical
phenotype typical of a corneal dermoid. Only one case [129]
did not show this and showed isolated iridocorneal adhesions.
Where  histopathology  was  available  [126,128],  this
confirmed features of choristoma. We suggest that an isolated
ocular  phenotype  of  corneal  dermoid  should  raise  the
possibility of a trisomy 8 mosaicism, as systemic features may
be very mild. This corneal dermoid is usually very flat with
reticular vascularisation.
Chromosome  9:  Of  the  two  reports  of  ASDA  with
abnormalities affecting chromosome 9, one is an interstitial
deletion between 9q22-q32 [130], and the other is a partial
trisomy 9 mosaicism [131]. In this latter report, the individual
is affected unilaterally only. Its significance, both because of
the mosaicism and the unilaterality, is unclear.
In the report of a deletion 9q22-q32, bilateral S-CNA is
reported [130]. Interestingly transforming growth factor beta
receptor 1 (TGFBR1) is located at 9q22. This is a cell receptor
regulating  TGFB-induced  transcription  of  target  genes,  in
particular  collagen  and  connective  tissue  growth  factor
[132]. One may speculate that disruption of this gene may lead
to perturbation of the extracellular matrix homeostasis within
the cornea.
On the other hand, there is a recent report by Hanna et al.
[133]  presenting  a  patient  with  unilateral  PA,  atypical
systemic associations, and a heterozygous deletion involving
the receptor tyrosine kinase-like orphan receptor 2 (ROR2)
gene on chromosome 9q22.31, another possibly implicated
gene in the case reported by Ying et al. [130].
Chromosome  10:  Partial  duplication  of  10q  has  been
shown to be associated with congenital glaucoma and S-CCO
[134]. In this case, at the time of PKP, total absence of iris was
found, leading us to suggest that this entity is total corneal
opacification secondary to an intraocular disruption.
Bilateral  S-CNA  was  reported  in  a  boy  with  an
unbalanced  translocation  involving  17p  and  10q
chromosomes  [135].  Although  detailed  location  of  the
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assume that this was another case of CCO resulting from 10q
disruption.
It is worth noting that fibroblast growth factor receptor 2
(FGFR2) is on chromosome 10q26. Mutations in this gene are
known to result in the craniosynostoses Crouzon, Apert, and
Pfeiffer syndromes [136]. There has been a report of ARA-
like changes in a patient with a FGFR2 mutation [20], as well
as features of PA in another patient [19]. Whether the above
duplication  results  in  a  very  severe  ARA-like  phenotype
resulting in absence of iris is unclear.
Yunis et al. [137] reported partial trisomy for 10q(ter),
resulting  in  bilateral  microphthalmia,  and  bilateral  lens
opacities with obliteration of anterior chamber. The retina was
replaced with fibrous tissue. Again it is worth noting that
known mutations in FGFR2 result in a gain of function.
Also, the transcription factor PITX3 lies in 10q25 [18,
138], and mutations in this gene are associated with “anterior
segment mesenchymal dysgenesis” including dense corneal
opacification (central or peripheral) with iris adhesion, i.e.,
Peters anomaly, and cataract.
Finally,  discrete  peripheral  S-CNA  with  prominent
Schwalbe's line, iris strand and iris hypoplasia consistent with
the  Rieger  anomaly  phenotype  is  described  in  a  case  of
deletion of 10p13 [139].
Chromosome 11: PAX6, on 11p13, is a homeobox gene
that is important in regulating the development of the eye.
Reports of del11p13 mosaicism, duplication of 11p12–13,
del(11)(p13p13), and deletion of 11p13–15, have all shown
features  typical  of  those  seen  in  aniridia:  hypoplastic  iris
stroma or absent iris, corectopia, as well as microphthalmos
with or without cyst, iridocorneal adhesions with secondary
corneal  opacity,  polar  cataract  and  foveal  hypoplasia
[140-144].
Of  some  interest  however  is  a  report  of  interstitial
deletion  of  11q  (either  11q14  or  11q22)  resulting  in
iridocorneal adhesion with secondary CCO in one eye, and
complete  iridocorneal  adhesion  in  the  other  eye  with
secondary  CCO  and  corneal  vascularisation  [145].  This
suggests  that  on  11q  a  gene  affecting  iridocorneal
development may also reside.
Chromosome 12: In a single report chromosome 12p
deletion  is  described  in  a  child  with  severe  S-CCO  with
advanced  glaucoma  [146].  That  CCO  is  described  with
corneal vascularisation. One eye had no evidence of a lens on
USS and the other had a lens. The CCO is secondary to
intraocular anomalies. No further history was available. This
case  demonstrated  severe  glaucoma,  anterior  segment
disruption and severe CCO. It is important to note that as far
back  as  1970  Zinn  had  shown  in  the  chick  embryo  that
removal of the developing lens resulted in an opaque cornea
[147].  Therefore,  the  CCO  described  here  is  likely  to  be
secondary to lens formation failure.
Chromosome 13: Association of interstitial deletion of
13q14-q22 with features of Rieger syndrome is suggested
based on two reported cases [148]. This is reinforced by a
study of a family with Rieger syndrome of variable severity
mapping the disease to 13q14 [149]. However, there were no
patients with primary corneal pathology in the above studies.
In addition, a sole case with trisomy 13 was reported with
PA as part of whole eye disruption and multiple systemic
abnormalities [150]. No conclusions can be drawn from this
association.
Chromosome 14: A single report presents the association
of 14q22.1–22.3 interstitial deletion and bilateral CCO [151].
The phenotype is not sufficiently described to ascertain if the
cornea  is  primarily  or  secondarily  involved.  The  authors
suggest  that  bone  morphogenetic  protein  4  (BMP4),
previously shown to be mutated in mice with anterior segment
abnormalities,  may  contribute  to  the  phenotype.  This
association is interesting but needs to be confirmed by further
studies.  This  is  probably  the  case,  as,  in  the  same  year,
Bakrania et al. [152] reported the association of a BMP4
mutation and anophthalmia-microphthalmia in two distinct
families.
Chromosome  17:  A  case  of  17q12  duplication  was
reported with sex reversal, PA, microphthalmia, glaucoma,
and systemic abnormalities [153]. The pathogenicity of this
genetic  defect  and  the  relevance  of  transcription  factor  2
(TCF2), a gene involved in diabetes-associated phenotypes
that lies on the duplicated area, is uncertain.
Chromosome 18: Trisomy 18 (Edwards' syndrome) has
been  associated  with  congenitally  opaque  corneas  with
absence  of  Bowman's  and  Descemet's  membrane,  and
superficial  conjunctival  vascularisation,  with  or  without
microphthalmia  [154,155].  However,  the  occurrence  of
normal corneas in other cases has led Mullaney et al. [156] to
hypothesize  that  CCO  in  the  former  paper  was  possibly
trophic (secondary) in origin. At the other end of the severity
spectrum, a case of primary congenital aphakia and anterior
segment aplasia was described by Johnson et al. [157]. It is
unsafe to draw conclusions about the nature of CCO in trisomy
18, based on these observations alone.
There has been an association of deletion of 18q with
CCO consistent with PA, and multiple systemic anomalies
[158], while deletion of 18q21 was reported in a child with
bilateral microphthalmia, microcornea, and unilateral inferior
corneal opacification [159]. A patient with right anophthalmia
and left S-CCO and persistent fetal vasculature, was found to
be a compound heterozygote for retina and anterior neural fold
homeobox (RAX) gene mutations [32]. The RAX homeobox
gene is on chromosome 18q21.3 and is crucial for the proper
formation of the optic vesicle. CCO in the above cases appears
to be secondary to whole globe disruption.
Additionally, a recent report associates the development
of Fuchs' dystrophy of the cornea with genetic variation in the
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q21.32 [160]. This gene encodes the protein E2–2, which is a
transcription  factor  expressed  in  the  developing  corneal
endothelium  and  involved  in  cellular  growth  and
differentiation.
Chromosome 21: Ring chromosome 21 was reported in
a boy with unilateral PA [161]. The unilaterality and mildness
of the phenotype suggests that this genetic abnormality had a
minor contribution to corneal morphogenesis.
Partial monosomy 21 was reported in a case with bilateral
S-CCO [162]. In fact, the karyotype is complex (45,XX,-6,-
der6t(6;21)(p25;q22.1)-21  and  the  translocation  present  in
this patient resulted in a derivative (6;21) chromosome, it is
thus unclear if the phenotype can be associated with gene
disruption at the breakpoints, the partial monosomy 21, or the
partial monosomy 6. An argument to suggest that 21q22 is
implicated  comes  from  three  reports  in  the  literature
associating CCO and 21q22 deletion [163-165]. CCO in these
cases  ranged  in  severity,  from  unilateral  to  bilateral  and
combined with severe microphthalmia. Once more, corneal
involvement appears to be secondary.
Chromosome 22: A large series of patients with 22q11.2
deletion syndrome describe common ocular findings, but not
of the cornea [166,167]. However, Casteels et al. [168] and
Erdogan et al. [169] each described a case of unilateral PA,
while Binenbaum et al. [170] showed several cases with a
spectrum of anterior segment anomalies, including S-CCO, S-
CNA,  descemetocele,  iridocorneal  adhesions  (PA),  and
severe  anterior  segment  dysgenesis.  This  latter  series  of
patients suggests that a gene/genes affecting anterior segment
embryogenesis  reside  at  the  22q11.2  locus.  It  could  be
hypothesized that disruption of the genes coding for crystallin
beta  1,  crystallin  beta  2,  and  crystallin  beta  3
(CRYBB1,CRYBB2, and CRYBB3), in 22q11.2, interferes with
normal lens formation, and secondarily with anterior segment
morphogenesis.  The  occurrence  of  cataract  is,  however,
scarce  in  this  syndrome  [171],  and  does  not  necessarily
accompany ASDA.
Comment:
Of the 111 papers included in this study for detailed
ocular  phenotype  analysis  and  genotype-phenotype
association, only 53 show a picture of the affected cornea/
anterior segment, while 29 show a picture of the face and 29
present no pictures at all. Histology findings are given in 16
of the 19 cases where corneal transplantation took place or
post-mortem autopsy was performed.
Out  of  the  28  papers  where  the  term  “sclerocornea”
appears, it was used to describe a CNA-like phenotype in only
13 papers (S-CNA), whereas in the remaining 15 it signified
total corneal opacification (S-CCO). Similarly, in 4 of the 17
papers where the term “Peters anomaly” was used, it described
a complete corneal opacity, without sonographic or histologic
evidence of iridocorneal or keratolenticular adhesions. Ocular
ultrasonography was used to better describe the phenotype in
only 4 papers [52,85,146,162] and ultrasound biomicroscopy
(UBM) in only one [104].
Reviewing the literature on chromosome anomalies and
associated CCO highlights how confusion may occur when a
clinical phenotype is mislabeled or inaccurately presented
(Figure 1 and Figure 3). This confusion may prevent useful
genotype-phenotype correlations from being identified and
the true nature of this spectrum of diseases and associated
genes  from  being  revealed.  From  the  data  provided,  we
attempted  to  summarize  associations  regarding  primary
corneal involvement (Table 2). This information may point to
possible candidate genes.
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TABLE 2. CHROMOSOME LOCI ASSOCIATED WITH CCO WITHOUT WHOLE GLOBE DISRUPTION ACCORDING TO CCO CLASSIFICATION USED IN THIS REVIEW.
Phenotype Associated loci Genes in the region, known to be associated 
with ASDA in humans or mice
CCO with iridocorneal or keratolenticular adhesions (PA)
 
mosaic trisomy 8 [129] ?
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